Search

Blog: Using viruses to treat antibiotic-resistant bacterial infections | National Institutes of Health (NIH).

Postdoc at UNC Chapel Hill to study the cell wall biogenesis of mycobacteria and to explore the potential of treating mycobacteria with bacteriophages.

Paper: Compassionate-use of phages in twenty patients with drug-resistant mycobacterial disease.

We are urgently seeking Serratia phages for a patient in the USA Ways to help at this stage: - By sending your phages for testing on the patient's strain - By receiving the strain and testing your phages - By receiving the strain and usin

We are urgently seeking Serratia phages for a patient in the USA Ways to help at this stage: - By sending your phages for testing on the patient's strain - By receiving the strain and testing your phages - By receiving the strain and usin

We are urgently seeking Serratia phages for a patient in the USA Ways to help at this stage: - By sending your phages for testing on the patient's strain - By receiving the strain and testing your phages - By receiving the strain and usin

Postdoc to study cell wall biogenesis of mycobacteria and explore treating mycobacteria with phages in Dr. Miriam Braunstein’s lab, which investigates basic biology and mechanisms of pathogenesis of mycobacteria.

Research assistant to join the Phage Therapy Working Group at University of Idaho to advance the principles of phage therapy using evolution.

Webinar: Embracing the Australian Pathway to Phage Therapy in Canada: Connect Globally, Act Locally. Hosted by AMMI (Association of Medical Microbiology and Infectious Disease Canada) Tuesday, June 28th at 6pm - 7pm EDT Ottawa (Wednesday,

News: Pherecydes Pharma announces the first international approval of a compassionate treatment with its phages.

Webinar: Embracing the Australian Pathway to Phage Therapy in Canada: Connect Globally, Act Locally. Hosted by AMMI (Association of Medical Microbiology and Infectious Disease Canada) Tuesday, June 28th at 6pm - 7pm EDT Ottawa (Wednesday,

Postdoctoral Fellowship at CSIRO in Phage Therapy Bioinformatics

Adaptive Phage Therapeutics announced that the first patient has been dosed in its DFO Adaptive Novel Care Evaluation (DANCE™) trial, a Phase 1/2 clinical study to evaluate the safety and efficacy of APT’s precision phage therapy in patient

News article: Rediscovering phages: ‘We finally have the tools to harness them’.

Armata Pharmaceuticals announces first patient dosed in phase 1b/2a 'diSArm' study of AP-SA02 in adults with bacteremia due to Staphylococcus aureus.

Paper: An anti-MRSA phage from raw fish rinse: stability evaluation and production optimization.

Register here to attend the upcoming ESGNTA online course on ‘personalised phage therapy: basic principles of monitoring and treatment’. The online course will run from 7 - 10 June, 2022 with a great line-up of experts in the field.

Paper: Phage-antibiotic combination is a superior treatment against Acinetobacter baumannii in a preclinical study. Also read this press release about the paper!

Paper: Combination of in vivo phage therapy data with in silico model highlights key parameters for pneumonia treatment efficacy. Also see this news article about the paper!

Paper: In vitro and in vivo assessments of two newly isolated bacteriophages against an ST13 urinary tract infection Klebsiella pneumoniae.